Viyash Scientific to acquire Italian firm BioForLife for ₹188 cr.
Viyash Scientific has agreed to acquire the Italian pet care firm BioForLife for approximately ₹188 crore. The acquisition aims to expand Viyash's product reach in Europe and introduce new pet care innovations to the Indian market.
Why it matters
This deal highlights the growing trend of Indian pharmaceutical companies diversifying into the global pet care and animal health sectors.
Viyash Scientific, through subsidiary Alivira Animal Health, has signed a binding agreement to acquire 100% stake in Italian pet care firm BioForLife Italia S.r.l. (BFL) for around Rs.188 crore.
The article provides a factual report on a corporate acquisition without emotive language or political framing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in